Results 351 to 360 of about 2,032,538 (389)
Some of the next articles are maybe not open access.
Bone Mass Is Low in Relatives of Osteoporotic Patients
Annals of Internal Medicine, 1988To determine whether the failure to attain normal bone mass in young adulthood contributes to the later development of osteoporotic fractures.Case-control study.Referral-based bone clinic at a large teaching hospital.Sequential sample of 35 asymptomatic relatives, aged 19 to 59 years, of patients with osteoporotic fractures, and 24 patients with ...
Mary Evans+5 more
openaire +3 more sources
The Association Between Cysteine, Bone Turnover, and Low Bone Mass
Calcified Tissue International, 2007With the identification of hyperhomocysteinemia as a risk factor for developing osteoporosis, the contribution of thiols metabolically linked with homocysteine (tHcy) may be of importance. Cysteine (Cys) is formed from tHcy and is involved in bone metabolism via incorporation into collagen and cysteine protease enzymes.We investigated the association ...
M. Baines+6 more
openaire +3 more sources
Promoting adherence to bone-loading exercises in postmenopausal women with low bone mass
Journal of the American Association of Nurse Practitioners, 2021ABSTRACT Background: We recently completed a parent study (Bone Loading Exercises versus Risedronate on Bone Health in Post-menopausal Women [NIH# R01NR015029]) examining bone-loading exercises to prevent bone loss in postmenopausal women with low bone mass.
Joan M. Lappe+5 more
openaire +2 more sources
Low bone mass in Pompe disease
Bone, 2010Pompe disease is an inherited metabolic myopathy caused by deficiency of acid alpha-glucosidase. The introduction of enzyme replacement therapy as treatment for the disease may change prospects for patients and may require that more attention be paid to co-morbidities such as osteoporosis.Bone mineral status was assessed in children and adults with ...
Linda E.M. van den Berg+8 more
openaire +3 more sources
Differential Diagnosis: Low Bone Mass
1998Low bone mass is necessary but not sufficient for osteoporosis and fracture. It is the major contributor to the risk of fracture in an individual patient, but other factors also come into play. These include age, previous fracture, family history of fracture, and frequency of falls.
Dorothy A. Nelson, Michael Kleerekoper
openaire +2 more sources
Hypermobility syndrome increases the risk for low bone mass
Clinical Rheumatology, 2005Few studies on the benign joint hypermobility syndrome suggest a tendency toward osteopenia, but there are conflicting results. We assessed bone mineral density in pre-menopausal women with hypermobility. Twenty-five consecutive Caucasian women diagnosed with benign hypermobility syndrome by Beighton score and 23 age- and sex-matched controls were ...
Peker, Ozlen+7 more
openaire +4 more sources
Prevalence of low bone mass in individuals with HIV infection
Medicina Clínica (English Edition), 2021Abstract Background and aims There are no population data on bone mass in individuals with HIV in Spain, adjusted for age and sex. Materials and methods Bone mineral density (BMD) data were obtained by dual X-ray absorptiometry in a cohort of individuals with HIV infection compared with cohort data from the general population in Spain and the ...
Pilar Vizcarra+5 more
openaire +2 more sources
Osteoporosis and Low Bone Mass in Premenopausal and Perimenopausal Women
Endocrine Practice, 2000To characterize the historical, clinical, and biochemical features of 111 young women (age,
Etah Kurland+9 more
openaire +3 more sources
Hemophilia, low bone mass, and osteopenia/osteoporosis
Transfusion and Apheresis Science, 2008A recent case series from Australia suggested that children with hemophilia may be more likely to have low bone density or osteopenia than healthy controls. This finding has led to uncertainty among patients and their physicians as to whether treatment with bisphosphonates is indicated to treat osteopenia and prevent osteoporosis in children or young ...
openaire +3 more sources
Journal of Women's Health, 2015
BACKGROUND Bone mineral density (BMD) loss among depot medroxyprogesterone acetate (DMPA) users is a controversial issue. Aspects under debate include whether the number of years of use has any effect on continuous BMD loss, whether this loss will ...
W. Modesto, M. Bahamondes, L. Bahamondes
semanticscholar +1 more source
BACKGROUND Bone mineral density (BMD) loss among depot medroxyprogesterone acetate (DMPA) users is a controversial issue. Aspects under debate include whether the number of years of use has any effect on continuous BMD loss, whether this loss will ...
W. Modesto, M. Bahamondes, L. Bahamondes
semanticscholar +1 more source